Sign in
Taking peopleNo phase

Study of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity

Key facts

Who runs it
Assistance Publique - Hôpitaux de Paris
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
70 people, planned
Started
1 Dec 2024
Expected to end
1 Sept 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Sulforaphane
  • Placebo
Record updated
6 November 2026

Who can take part

Age
6 years to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Children aged 6 to 12
  • Diagnosis of ADHD according to DSM-5 criteria (Diagnostic and Statistical Manual of Mental Disorders)
  • Followed or hospitalised in an investigating centre
  • Consent of holders of parental authority
  • Patient covered by health insurance (social security or CMU)
  • Patients able to swallow capsules

Who cannot take part

  • Psychotropic treatment including methylphenidate in the month prior to inclusion
  • Previous intake of sulforaphane
  • Participation in other interventional research involving the human person or being within the exclusion period following previous research involving the human person, where applicable
  • Allergy to broccoli
  • ASD (Autism Spectrum Disorder) according to DSM-5 criteria, intellectual disability (IQ< 80)
  • Chronic neurological disease, epilepsy
  • Ongoing psychotherapeutic and/or psycho-educational treatment specific to ADHD
  • Holders of parental authority under guardianship or curatorship
  • Known hypothyroidism or current thyroid treatment
  • Patient under AME (state medical aid)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 12 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

ADHD is a neurodevelopmental disorder. It is the most common neurodevelopmental disorder in children and adolescents. Its prevalence is estimated at 5.9% in this population. The symptoms of ADHD combine attention deficit with behavioural disorders such as hyperactivity and impulsivity. Current treatment for ADHD is based on psychotherapeutic and psychoeducational measures aimed at improving behaviour and its impact on the family, social and school environment. Drug treatments may also be used, depending on the impact of the disorder and the effectiveness of alternative treatments. Psychostimulants such as amphetamine derivatives and methylphenidate are around 80% effective.

Read full original descriptionShow less

Sulforaphane is an active substance derived from broccoli that has already been tested in the treatment of other neurodevelopmental disorders. The main hypothesis is that sulforaphane is effective in treating the symptoms of Attention Deficit Disorder with or without Hyperactivity (ADHD) in children.

The 2 groups in the trial

  • SulforaphaneTreatment being tested

    Prostaphane® is a dietary supplement based on SULFODYNE®, a broccoli seed extract standardised in free, stabilised sulforaphane. Patients will receive treatment for 8 weeks at the following dosage: * 1 capsule/day up to 50 kg, * 2 capsules/day from 50.1 to 90 kg; * 3 capsules/day above 90 kg, Each capsule contains 10mg of Sulforaphane.

  • PlaceboPlacebo, for comparison

    Patients will receive treatment for 8 weeks at the following dosage: * 1 capsule/day up to 50 kg, * 2 capsules/day from 50.1 to 90 kg; * 3 capsules/day above 90 kg, Each capsule contains placebo.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Fit questions
Built from NCT06594536, who can take part
Record updated
6 November 2026